Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety of ATLAS 2030 in the Application of Robot-assisted Physical Therapy to Children With Neuromuscular Diseases Phase I

NCT04837157 is registered in ClinicalTrials.gov with MarsiBionics as lead sponsor.

NCT NCT04837157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04837157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety of ATLAS 2030 in the Application of Robot-assisted Physical Therapy to Children With Neuromuscular Diseases Phase I
Lead sponsor
MarsiBionics
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2020
Completion date
January 31, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy, neuromuscular diseases, sma ii